This article discusses the background and the main stages of development and adoption of the Cartagena Protocol on Biosafety 2000 to the UN Convention on Biological Diversity in 1992 as a unique international agreement designed to promote sustainable use of biological resources for economic and social development and environmental protection through the creation of international legal regime to maintain the safe transboundary movement , handling and use of living modified organisms (LMOs) resulting from the application of modern biotechnology
The Cartagena Protocol, made under the Convention on Biological Diversity, aims at protecting the ‘...
At Rio de Janeiro in 1992, during the course of the Earth Summit and specifically in relation to Age...
Purpose – When genetically modified organisms (GMOs) were put into the international trade, people i...
Modern biotechnology - the controversial manipulation of genes in living organisms - has far-reachin...
The Cartagena Protocol on Biosafety was adopted by 150 countries in January 2000 to regulate the tra...
The exponential growth in the use and trade of living modified organisms (LMOs) has made the safe us...
Biotechnology or the engineering of the genetic material of species can give way to avenues of possi...
Biotechnology or the engineering of the genetic material of species can give way to avenues of possi...
In a meeting in Cartagena, Colombia in February 1999, parties to the CBD, known as the Conference of...
The article is part of a broader research on compliance mechanisms and on their role in dealing with...
In January 2000, delegates from over 100 nations completed negotiations on an international treaty f...
29 January 2000 as a supplementary agreement to the Convention on Biological Diversity) that address...
Biotechnology or the engineering of the genetic material of species can give way to avenues of possi...
Although modern biotechnology holds great potential for agriculture, especially in developing count...
The recent worldwide commercialisation of genetically modified organisms (GMOs), called also living ...
The Cartagena Protocol, made under the Convention on Biological Diversity, aims at protecting the ‘...
At Rio de Janeiro in 1992, during the course of the Earth Summit and specifically in relation to Age...
Purpose – When genetically modified organisms (GMOs) were put into the international trade, people i...
Modern biotechnology - the controversial manipulation of genes in living organisms - has far-reachin...
The Cartagena Protocol on Biosafety was adopted by 150 countries in January 2000 to regulate the tra...
The exponential growth in the use and trade of living modified organisms (LMOs) has made the safe us...
Biotechnology or the engineering of the genetic material of species can give way to avenues of possi...
Biotechnology or the engineering of the genetic material of species can give way to avenues of possi...
In a meeting in Cartagena, Colombia in February 1999, parties to the CBD, known as the Conference of...
The article is part of a broader research on compliance mechanisms and on their role in dealing with...
In January 2000, delegates from over 100 nations completed negotiations on an international treaty f...
29 January 2000 as a supplementary agreement to the Convention on Biological Diversity) that address...
Biotechnology or the engineering of the genetic material of species can give way to avenues of possi...
Although modern biotechnology holds great potential for agriculture, especially in developing count...
The recent worldwide commercialisation of genetically modified organisms (GMOs), called also living ...
The Cartagena Protocol, made under the Convention on Biological Diversity, aims at protecting the ‘...
At Rio de Janeiro in 1992, during the course of the Earth Summit and specifically in relation to Age...
Purpose – When genetically modified organisms (GMOs) were put into the international trade, people i...